Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.

In recent years, the number of electric bicycle users in Vietnam has increased sharply, leading to the need to upgrade ...

To mark objects as Assets in your Asset Browser, right-click an object in your outliner and click ‘Mark an Asset’. Go to ...

Abstract: Recently, a severe danger has evolved regarding the explosion of Electric Vehicle (EV) batteries due to their thermal issues. A proficient system is employed for managing the operations of ...

This is a Python module for reading data from Daly BMS devices. It supports serial as well as Bluetooth connections. Not all commands that the BMS supports are implemented yet, please take a look at ...

I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, these ...

foxBMS is a free, open and flexible development environment to design battery management systems. It is the first modular open source BMS development platform. foxBMS is an universal hardware and ...